YOLFTbeta
Diamond Biotechnology Co., Ltd

Diamond Biotechnology Co., Ltd

6815 · TWO · Healthcare / Medical Devices

18.00TWD-0.80 (-4.26%)

Price History

Full chart

Market Stats

Previous Close18.80
Open18.45
Day Range17.90 – 18.50
52-Week Range21.90 – 77.30
Volume30.22K
Market Cap890.57M
P/E (TTM)0.00
Forward P/E0.00
EPS-1.20
Dividend Yield0.00%
Beta0.29
50-Day Avg24.25
200-Day Avg38.83

About

Diamond Biotechnology Co., Ltd engages in the research, development, manufacture, and sale of health care products and medical consumables in Taiwan and internationally. The company offers Miracle Thread, an absorbable synthetic surgical suture device made of polydioxanone; UTIMS, a high-intensity focused ultrasound; Letybo, a frozen crystal injection; TEOSYAL RHA invisible resilient hyaluronic acid; Ronkyla, a sodium deoxycholate injection; S+DIAMOND skincare products. It also sells and leases medical equipment. The company was founded in 2014 and is based in Taipei, Taiwan.

Company Details

Leadership

  • Jiaxian XieGM & Director
  • Ting Yu ZhangAccounting Supervisor

Financials

Income Statement

Currency: TWD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue268.35M306.39M395.20M434.84M616.10M768.25M501.49M
Growth (%)-+14.17%+28.99%+10.03%+41.68%+24.70%-34.72%
Cost of Revenue133.59M177.96M207.32M250.53M326.50M437.54M346.25M
Gross Profit134.77M128.43M187.88M184.32M289.59M330.71M155.25M
Gross Margin50.22%41.92%47.54%42.39%47.00%43.05%30.96%
Operating Expense78.47M113.44M139.79M137.91M225.69M217.96M229.44M
Operating Income56.30M14.99M48.09M46.41M63.91M112.75M-74.19M
Operating Margin20.98%4.89%12.17%10.67%10.37%14.68%-14.79%
EBITDA79.07M70.81M112.72M99.04M116.17M131.16M-45.94M
EBITDA Margin29.47%23.11%28.52%22.78%18.86%17.07%-9.16%
Net Income44.18M11.05M41.92M33.39M46.74M73.20M-70.31M
Net Income Margin16.46%3.61%10.61%7.68%7.59%9.53%-14.02%
R&D1.12M2.89M27.93M25.94M29.33M41.40M47.49M
R&D as % of Total Revenue0.42%0.94%7.07%5.96%4.76%5.39%9.47%
Interest Expense1.13M2.48M2.27M3.74M7.52M7.44M5.19M
Interest Expense % of Total Revenue0.42%0.81%0.58%0.86%1.22%0.97%1.03%

Balance Sheet

Currency: TWD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets470.12M437.76M540.94M630.46M798.91M1.06B868.96M
Total Liabilities1.74M205.58M267.83M327.77M452.52M433.28M327.12M
Total Equity250.44M232.19M273.11M302.69M346.39M623.05M541.83M
Cash56.53M62.36M51.21M98.47M78.52M156.10M146.09M
Total Debt117.36M151.47M180.04M214.90M352.69M251.58M-
Net Debt60.83M89.11M128.83M116.43M274.17M95.48M83.16M

Cash Flow

Currency: TWD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow23.16M71.17M5.64M157.53M40.90M33.70M-2.08M
Investing Cash Flow-31.77M-26.85M-52.11M-132.57M-196.31M-81.89M-
Financing Cash Flow23.03M-38.46M35.32M22.29M135.46M125.98M-
Capital Expenditure16.56M56.97M24.90M72.96M196.62M30.20M1.13M
Free Cash Flow6.60M14.20M-19.25M84.57M-155.72M3.50M-3.22M
Dividends Paid36.30M29.28M994.00K3.81M3.02M4.95M6.57M
FCF to OCF28.49%19.95%-341.03%53.68%-380.70%10.39%154.39%
Dividend Paid to FCF550.25%206.21%-5.16%4.51%-1.94%141.31%-204.04%

Key Statistics & Ratios

Market Cap890.57M
Enterprise Value886.33M
Trailing P/E0.00
Forward P/E0.00
Price / Sales1.92
Price / Book1.62
EPS-1.20
Book Value14.49
Revenue (TTM)464.63M
Gross Profit (TTM)180.48M
EBITDA-32.78M
Profit Margin-10.24%
Operating Margin15.90%
Return on Equity-7.98%
Return on Assets-3.71%
Shares Outstanding39.49M
Shares Float20.65M
Beta0.29
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio16.13%

Dividends

20251×
0.20Aug 27, 2025
20241×
0.14Aug 5, 2024
20231×
0.09Aug 23, 2023
20221×
0.12Aug 24, 2022
20211×
0.03Aug 27, 2021

Stock Splits

  • Aug 27, 20251176.017:1000
  • Aug 5, 20241123.3191:1000
  • Aug 23, 20231109.1:1000
  • Aug 24, 20221158.55:1000
  • Aug 27, 20211043.6:1000